biologics

R&D

Is the future of pharmaceutical drugs in the delivery?

Pharmaceutical drugs have seen a seismic shift over the past ten years, moving away from chemically synthesised drugs to focus more on a new class of biological drugs (biologics).<

News

AstraZeneca links with Absci on AI for biologics discovery

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-

News

Sanofi partners BioMap on AI hunt for biologic therapies

Sanofi has added another dimension to the use of artificial intelligence (AI) to seek out new drugs, partnering with BioMap on a project to find biologic therapies in a de

R&D

Partner Content

Advanced Purification for Complex Biologics Summit

Empower your downstream process optimization to remove purification bottlenecks & achieve 100% product purity

R&D

Partner Content

7th IPF Summit

Now in its 7th year, this is the undisputed (and only!) meeting dedicated to harnessing emerging biological understanding, employing novel preclinical models to cement translational confide

R&D